Centessa Pharmaceuticals (CNTA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Centessa Pharmaceuticals

    NASDAQ: CNTA · Real-Time Price · USD
    23.26
    0.25 (1.09%)
    At close: Sep 26, 2025, 3:59 PM
    23.72
    1.98%
    After-hours: Sep 26, 2025, 06:38 PM EDT

    Centessa Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 6.85M n/a n/a
    Cost of Revenue
    		 942.4K 813.14K n/a 33.99K
    Gross Profit
    		 -942.4K 6.85M -131K -33.99K
    Operating Income
    		 -201.06M -171.28M -212.26M -10.44M
    Interest Income
    		 14.02M 10.48M 7.03K 2.55K
    Pretax Income
    		 -233.01M -176.14M -216.95M -381.74M
    Net Income
    		 -235.76M -151.09M -216.21M -10.66M
    Selling & General & Admin
    		 50.81M 53.73M 55.2M 42.97M
    Research & Development
    		 181.19M 124.41M 155.08M 96.31M
    Other Expenses
    		 -30.94M n/a n/a n/a
    Operating Expenses
    		 201.06M 178.14M 210.28M 10.44M
    Interest Expense
    		 10.09M 9.91M 7.03M 2.55M
    Selling & Marketing Expenses
    		 n/a n/a n/a 42.93M
    Cost & Expenses
    		 201.06M 178.14M 210.28M 139.31M
    Income Tax Expense
    		 2.84M -25.06M -747K 113.99K
    Shares Outstanding (Basic)
    		 114.47M 96.18M 93.4M 89.99M
    Shares Outstanding (Diluted)
    		 114.47M 96.18M 93.4M 89.99M
    EPS (Basic)
    		 -2.06 -1.57 -2.31 -4.24
    EPS (Diluted)
    		 -2.06 -1.57 -2.31 -4.24
    EBITDA
    		 -221.97M -166.07M -207.81M -379.16M
    EBIT
    		 -222.92M -166.88M -209.79M -139.33M
    Depreciation & Amortization
    		 942.4K 813.14K 130.92K 33.99K

    Add to Watchlist